• More Positive Spravato Data; Vyvanse for Amphetamine Disorders; Psych Pioneer Dies

    11 days ago - By MedPageToday

    Results from the phase IIIb ESCAPE-TRD trial among patients with treatment-resistant depression showed that esketamine nasal spray was superior to extended-release quetiapine for symptom remission at...
    Read more ...